These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 10768158
1. [Vigabatrin in the treatment of intractable focal epilepsy in children and adolescents. Two-year study]. Kozik A, Ujma-Czapska B, Grotowska M. Neurol Neurochir Pol; 2000; 34 Suppl 1():187-93. PubMed ID: 10768158 [Abstract] [Full Text] [Related]
2. Vigabatrin in pediatric patients with refractory epilepsy. Turanli G, Celebi A, Yalnizoğlu D, Topçu M, Topaloğlu H, Banu A, Aysun S. Turk J Pediatr; 2006; 48(1):25-30. PubMed ID: 16562782 [Abstract] [Full Text] [Related]
3. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood. McDonald DG, Najam Y, Keegan MB, Whooley M, Madden D, McMenamin JB. Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564 [Abstract] [Full Text] [Related]
4. [Clinical analysis of the effectiveness and safety of vigabatrin]. Jedrzejczak J, Owczarek K. Neurol Neurochir Pol; 2000 Mar; 34 Suppl 1():177-85. PubMed ID: 10768157 [Abstract] [Full Text] [Related]
5. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Camposano SE, Major P, Halpern E, Thiele EA. Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386 [Abstract] [Full Text] [Related]
6. [Vigabatrin in childhood epilepsy--personal experience]. Zubcević S, Gavranović M, Catibusić F, Uzicanin S, Buljina A. Med Arh; 1999 Jul; 53(3 Suppl 2):63-5. PubMed ID: 10758766 [Abstract] [Full Text] [Related]
7. A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children. Sobaniec W, Kułak W, Strzelecka J, Smigielska-Kuzia J, Boćkowski L. Pharmacol Rep; 2005 Jul; 57(5):646-53. PubMed ID: 16227648 [Abstract] [Full Text] [Related]
8. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy. Kluger G, Berz K, Holthausen H. Eur J Paediatr Neurol; 2001 Jul; 5(1):37-40. PubMed ID: 11277363 [Abstract] [Full Text] [Related]
9. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex. Friedman D, Bogner M, Parker-Menzer K, Devinsky O. Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947 [Abstract] [Full Text] [Related]
10. Visual fields at school-age in children treated with vigabatrin in infancy. Gaily E, Jonsson H, Lappi M. Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279 [Abstract] [Full Text] [Related]
11. Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy. The Canadian Vigabatrin Study Group. Guberman A, Bruni J. Seizure; 2000 Mar; 9(2):112-8. PubMed ID: 10845734 [Abstract] [Full Text] [Related]
12. Is visual field constriction in epilepsy patients treated with vigabatrin reversible? Schmidt T, Rüther K, Jokiel B, Pfeiffer S, Tiel-Wilck K, Schmitz B. J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456 [Abstract] [Full Text] [Related]
13. The role of vigabatrin in childhood seizure disorders: results from a clinical audit. Prasad AN, Penney S, Buckley DJ. Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785 [Abstract] [Full Text] [Related]
14. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Luszczki JJ, Czuczwar SJ. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):529-38. PubMed ID: 17204358 [Abstract] [Full Text] [Related]
15. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group. Bruni J, Guberman A, Vachon L, Desforges C. Seizure; 2000 Apr 30; 9(3):224-32. PubMed ID: 10777431 [Abstract] [Full Text] [Related]
16. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA. Pediatrics; 2006 Aug 30; 118(2):e371-8. PubMed ID: 16847080 [Abstract] [Full Text] [Related]
17. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics. Mueller SG, Weber OM, Duc CO, Weber B, Meier D, Russ W, Boesiger P, Wieser HG. Epilepsia; 2001 Jan 30; 42(1):29-40. PubMed ID: 11207782 [Abstract] [Full Text] [Related]
18. Vigabatrin and epilepsy: lessons learned. Wild JM, Ahn HS, Baulac M, Bursztyn J, Chiron C, Gandolfo E, Safran AB, Schiefer U, Perucca E. Epilepsia; 2007 Jul 30; 48(7):1318-27. PubMed ID: 17635558 [Abstract] [Full Text] [Related]
19. Dose-response study of vigabatrin in children with refractory epilepsy. Herranz JL, Arteaga R, Farr IN, Valdizan E, Beaumont D, Armijo JA. J Child Neurol; 1991 Jul 30; Suppl 2():S45-51. PubMed ID: 1940124 [Abstract] [Full Text] [Related]
20. [Vigabatrin: results with a new antiepileptic agents in 57 patients in a general neurological practice]. van der Zwan A, van der Zwan A. Ned Tijdschr Geneeskd; 1994 Sep 10; 138(37):1859-63. PubMed ID: 7935922 [Abstract] [Full Text] [Related] Page: [Next] [New Search]